A 61-Year-Old Woman with Transplant-Preferred Newly Diagnosed Multiple Myeloma (NDMM)

home / case-based-peer-perspectives / a-61-year-old-woman-with-transplant-preferred-newly-diagnosed-multiple-myeloma-ndmm

Natalie Callander, MD, presents the case of a patient with transplant-preferred newly diagnosed multiple myeloma and reviews treatment paradigms and clinical trial data.

Natalie Callander, MD, an expert on multiple myeloma

EP. 1: Patient Profile: A 61-Year-Old Woman with Transplant-Preferred Newly Diagnosed Multiple Myeloma

Natalie S. Callander, MD
May 5th 2023

Natalie Callander, MD, presents the case of a 61-year-old woman with transplant-preferred newly diagnosed multiple myeloma (NDMM) and offers her initial impressions.

Watch

Natalie Callander, MD, an expert on multiple myeloma

EP. 2: Overview of Treatments and Role of Stem Cell Transplantation for Patients With NDMM

Natalie S. Callander, MD
May 5th 2023

An expert oncologist discusses the role of stem cell transplantation and currently available therapies for the treatment of newly diagnosed multiple myeloma.

Watch

Natalie Callander, MD, an expert on multiple myeloma

EP. 3: GRIFFIN Trial: D-RVd in Transplant-Preferred Newly Diagnosed MM

Natalie S. Callander, MD
May 5th 2023

Natalie Callander, MD, reviews the results and quality-of-life outcomes from the GRIFFIN trial on Dara-RVd for patients with transplant-eligible NDMM.

Watch

Natalie Callander, MD, an expert on multiple myeloma

EP. 4: Subgroup Analysis of MASTER Trial for Newly Diagnosed MM

Natalie S. Callander, MD
May 5th 2023

Insights on how the subgroup analysis of the MASTER trial informs the role of autologous stem cell transplantation and the use of quadruplet therapy for elderly patients.

Watch

Natalie Callander, MD, an expert on multiple myeloma

EP. 5: Impact of Quadruplet Therapy on Patients with High-Risk NDMM

Natalie S. Callander, MD
May 5th 2023

Natalie Callander, MD, details findings from her study, evaluating the impact of quadruplet therapy on newly diagnosed patients with high-risk multiple myeloma.

Watch

Natalie Callander, MD, an expert on multiple myeloma

EP. 6: Recent Data on Other Regimens for Newly Diagnosed Multiple Myeloma

Natalie S. Callander, MD
May 5th 2023

An overview of recent data from the SKylaRK and GMMG-HD7 trials evaluating non-daratumumab-based regimens for patients with transplant-preferred NDMM.

Watch

Natalie Callander, MD, an expert on multiple myeloma

EP. 7: Unmet Needs and Advice for Community Oncologists Treating Patients With NDMM

Natalie S. Callander, MD
May 5th 2023

Natalie Callander, MD, offers advice for community oncologists and discusses unmet needs in treating transplant-preferred patients with newly diagnosed MM.

Watch